Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HSV amplicons: neuro applications.

Carolyn M Tyler1, Charles A Wuertzer, William J Bowers

  • 1Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.

Current Gene Therapy
|June 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson's disease: Insights from non-human primate studies.

Brain research bulletin·2025
Same author

Autologous vs heterologous cell replacement strategies for Parkinson disease and other neurologic diseases.

Handbook of clinical neurology·2024
Same author

Preface.

Handbook of clinical neurology·2024
Same author

Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.

Brain : a journal of neurology·2023
Same author

E.L., a modern-day Phineas Gage: Revisiting frontal lobe injury.

Lancet regional health. Americas·2023
Same author

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's disease.

GeroScience·2022

Herpes simplex virus (HSV) amplicon vectors show promise for treating central nervous system (CNS) disorders by enabling neuroprotection, neuroplasticity, or immune responses. Research highlights their successes and challenges in neural network research and therapeutics.

Area of Science:

  • Neuroscience
  • Gene Therapy
  • Virology

Background:

  • Central nervous system (CNS) disorders present significant therapeutic challenges.
  • Herpes simplex virus (HSV) amplicon vectors offer a versatile platform for gene delivery.
  • Preclinical models extensively document strategies using HSV amplicon vectors for CNS conditions.

Purpose of the Study:

  • To review the application of HSV amplicon vectors in preventing or ameliorating CNS pathogenic states.
  • To highlight the use of HSV amplicon vectors for dissecting neural network function.
  • To discuss the potential of HSV amplicon vectors as therapeutics for neurologic disorders.

Main Methods:

  • Utilizing HSV amplicon vectors for gene expression of neuroprotective or neuroplastic factors.

Related Experiment Videos

  • Employing HSV amplicon vectors to elicit antigen-specific immune responses against CNS pathogens.
  • Investigating HSV amplicon vectors as tools for neural network analysis in preclinical models.

    • Main Results:

    • HSV amplicon vectors facilitate the expression of therapeutic genes within the CNS.
    • The platform supports the development of immune responses targeting CNS pathogenic elements.
    • Successful applications in preclinical models demonstrate potential for treating CNS disorders.

    Conclusions:

    • HSV amplicon vectors are versatile tools for both understanding and treating CNS disorders.
    • The technology enables targeted gene delivery for neuroprotection, neuroplasticity, and immunotherapy.
    • Further research is needed to address challenges and optimize HSV amplicon vector applications in the CNS.